Orchard Therapeutics
ORTX
$0.54
Share price
-4.64%
Change (1 day)
-54.24%
Change (1 year)
Market capitalization of Orchard Therapeutics (ORTX)
Market cap: $68.41 Million
As of February 2023 Orchard Therapeutics has a market cap of $68.41 Million. This makes Orchard Therapeutics the world's 6749th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Orchard Therapeutics from 2018 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $68.41 M | 45.55% |
| 2022 | $47 M | -71.63% |
| 2021 | $0.16 B | -60.98% |
| 2020 | $0.42 B | -68.14% |
| 2019 | $1.33 B | -1.33% |
| 2018 | $1.35 B |
End of Day market cap according to different sources
On Feb 6th, 2023 the market cap of Orchard Therapeutics was reported to be:
$68.41 Million
$68.41 Million
$68.42 Million
$68.93 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $14.37 M | -78.99% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $68.41 M | 0.00% | 🇬🇧 UK |
 Novavax NVAX | $0.94 B | 1,277.95% | 🇺🇸 USA |
 Novocure
NVCR | $9.64 B | 13,996.61% | Jersey |